KZA 0.00% 65.0¢ kazia therapeutics limited

novogen, page-7

  1. 25,374 Posts.
    lightbulb Created with Sketch. 2
    chart Feel like a shag on a rock ( anywheres ok with me)
    following rept at 18:06
    IND Approval From FDA - Phenoxodiol Oral Form Phase II Study


    HOMEX - Sydney

    Novogen Limited's subsidiary, Marshall Edwards Inc (LSE-AIM: MSH),
    has just made the following announcement to the London Stock
    Exchange's Alternative Investment Market.

    (WASHINGTON, DC June 17, 2003) Marshall Edwards Inc, subsidiary of
    Novogen Limited (NASDAQ: NVGN) announced today that an
    Investigational New Drug application (IND) has been cleared by the US
    Food and Drug Administration (FDA) for the start of a phase II
    clinical trial of phenoxodiol, administered orally, to women with
    squamous cell carcinoma (SCC) of the cervix, vagina and vulva.
    anyway here are a couple of charts
    paste url if interested
    this shows the Chande momentum oscillator tops in yellow

    Chande Price target Blue horizontal lines
    and Presto magic box set at 5 periods
    candle shows long lower shadow which did go close to filling the gap.....476-485
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Mkt cap ! $46.90M
Open High Low Value Volume
65.0¢ 65.0¢ 62.0¢ $16.64K 25.98K

Buyers (Bids)

No. Vol. Price($)
1 15000 64.0¢

Sellers (Offers)

Price($) Vol. No.
65.0¢ 3687 1
View Market Depth
Last trade - 15.42pm 06/12/2019 (20 minute delay) ?
0.000 ( 3.76 %)
Open High Low Volume
62.0¢ 64.0¢ 62.0¢ 6680
Last updated 14.35pm 06/12/2019 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.